Status:
RECRUITING
Zinc as an Adjunctive Therapy for Cervical Dystonia
Lead Sponsor:
University of Florida
Conditions:
Cervical Dystonia
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The goal of this clinical trial is to evaluate if supplemental zinc can prolong the duration of benefit of botulinum toxin injections in cervical dystonia patients receiving care at the University of ...
Detailed Description
Study Design: * Randomized, single-blind, crossover placebo-controlled trial. * Participants: Approximately 20 patients diagnosed with cervical dystonia and currently receiving botulinum toxin (BoNT)...
Eligibility Criteria
Inclusion
- Adults aged 18-65 years.
- Diagnosed with cervical dystonia.
- Receiving regular BoNT type A (Botox) injections for at least one year.
Exclusion
- Known allergy or intolerance to zinc.
- Significant comorbidities or concurrent medications that could interfere with study outcomes.
- Pregnant or breastfeeding women.
Key Trial Info
Start Date :
September 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07140874
Start Date
September 17 2025
End Date
June 1 2026
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norman Fixel Institute for Neurological Diseases
Gainesville, Florida, United States, 32608